Delivery Order SPE2DX15D3003-SPE2DX24F5M0F
Award Date 3/4/24
Potential Completion Date 3/25/24
Potential Value $17K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $84,720.33 firm-fixed-price delivery order is for the supply of 4560341607 Calquence 100 mg Tablet 60s. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a $17,150.74 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565426390 - CALQUENCE 100 MG TABLET 60S and has a completion date of September 3, 2024. AmerisourceBergen is a large pharmaceutical distributor that supplies a wide range of medical products to federal agencies, including the military. This delivery order contract is part of a larger Indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $17,150.74 firm fixed-price contract is for the supply of 4564313869 - CALQUENCE 100 MG TABLET 60S, with a period of performance through May 8, 2024. This order is placed under Amerisourcebergen's $999,999,999.00 single-award...
- This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,150.74, is for the delivery of Calquence 100 mg tablets. The order has a firm fixed price and is set to be completed by June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $17,150.74 worth of CALQUENCE 100 MG TABLET 60S pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as a single-award contract for the provision of a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,593.77, is for the supply of Calquence 100 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,150.74 firm fixed-price contract is for the delivery of the brand-name medication CALQUENCE 100 MG TABLET 60S, with a completion date of November 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $34,301.44 firm fixed price delivery order is for the pharmaceutical product CALQUENCE 100 MG TABLET 60S, with a performance period through April 8, 2024. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceutical products and medical supplies to the Department of Defense through...
- The Defense Logistics Agency (DLA) awarded a $17,150.74 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product CALQUENCE 100 MG TABLET 60S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Calquence 100 mg tablet. The $5,593.77 firm fixed-price contract has a completion date of June 4, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- SPE2DX15D3003Indefinite Delivery Contract
- SPE2DX15D3003-SPE2DX24F5M0FDelivery Order
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $17,150.74 order is for the supply of Calquence 100 MG tablets, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceuticals and medical supplies in support of military treatment programs and facilities worldwide. The IDC does not have any set-aside designations and was awarded solely to Amerisourcebergen Drug Corp.
Generated 6/3/24, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 3/4/24 |